Rompharm starts its activity in 2004 with the first GMP approved facility consisting of two production lines: one for sterile solutions/suspensions (eye drops) and the second for non sterile solutions/suspensions (oral drops, nasal drops/spray, topic solution/spray).To further extend our product range in December 2007 we had started the third facility for injection solutions aseptically produced, with a capacity of 100 million...
Rompharm starts its activity in 2004 with the first GMP approved facility consisting of two production lines: one for sterile solutions/suspensions (eye drops) and the second for non sterile solutions/suspensions (oral drops, nasal drops/spray, topic solution/spray).To further extend our product range in December 2007 we had started the third facility for injection solutions aseptically produced, with a capacity of 100 million ampoules per year.in 2012, Rompharm Company gladly announces the commissioning of its new facility for manufacturing of prefilled syringes and solutions for perfusion.
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.